Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| No statute on record | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GODDARD, LAURA B | 1 | 50.7% | +14.6% |
| WESTON, ALYSSA G | 1 | 63.0% | +49.7% |
| GONZALES, JOSEPHINE MARIA | 1 | 29.8% | +42.1% |
| DHAR, MATASHA | 1 | 44.7% | +50.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17438317 | CD3 RECONSTITUTION IN ENGINEERED iPSC AND IMMUNE EFFECTOR CELLS | GONZALES, JOSEPHINE MARIA | 27d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17040951 | ENGINEERED IMMUNE EFFECTOR CELLS AND USE THEREOF | DHAR, MATASHA | 44d overdue |
| 17782600 | ENHANCEMENT OF iPSC-DERIVED EFFECTOR IMMUNE CELL USING SMALL COMPOUNDS | WESTON, ALYSSA G | 30d overdue |
| 18028457 | ENGINEERED iPSC AND ARMED IMMUNE EFFECTOR CELLS | GODDARD, LAURA B | 1d overdue |
| 17438317 | CD3 RECONSTITUTION IN ENGINEERED iPSC AND IMMUNE EFFECTOR CELLS | GONZALES, JOSEPHINE MARIA | 27d |
| Art Unit | Apps |
|---|---|
| 1642 | 1 |
| 1633 | 1 |
| 1631 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18028457 | ENGINEERED iPSC AND ARMED IMMUNE EFFECTOR CELLS | GODDARD, LAURA B | 1642 | Other | Non-Final OA | 1d overdue | Pending | Mar 24, 2023 |
| 17782600 | ENHANCEMENT OF iPSC-DERIVED EFFECTOR IMMUNE CELL USING SMALL COMPOUNDS | WESTON, ALYSSA G | 1633 | Other | Final Rejection | 30d overdue | Pending | Jun 03, 2022 |
| 17438317 | CD3 RECONSTITUTION IN ENGINEERED iPSC AND IMMUNE EFFECTOR CELLS | GONZALES, JOSEPHINE MARIA | 1631 | §103 | Final Rejection | 27d | Pending | Sep 10, 2021 |
| 17040951 | ENGINEERED IMMUNE EFFECTOR CELLS AND USE THEREOF | DHAR, MATASHA | 1632 | §103 | Non-Final OA | 44d overdue | Pending | Sep 23, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial